60 related articles for article (PubMed ID: 11145463)
1. Neuroleptic therapy influences basal ganglia activation: a functional magnetic resonance imaging study comparing controls to haloperidol- and olanzapine-treated inpatients.
Müller JL; Klein HE
Psychiatry Clin Neurosci; 2000 Dec; 54(6):653-8. PubMed ID: 11145463
[TBL] [Abstract][Full Text] [Related]
2. Subcortical overactivation in untreated schizophrenic patients: a functional magnetic resonance image finger-tapping study.
Müller JL; Röder C; Schuierer G; Klein HE
Psychiatry Clin Neurosci; 2002 Feb; 56(1):77-84. PubMed ID: 11929574
[TBL] [Abstract][Full Text] [Related]
3. Motor-induced brain activation in cortical, subcortical and cerebellar regions in schizophrenic inpatients. A whole brain fMRI fingertapping study.
Müller JL; Röder CH; Schuierer G; Klein H
Prog Neuropsychopharmacol Biol Psychiatry; 2002 Apr; 26(3):421-6. PubMed ID: 11999890
[TBL] [Abstract][Full Text] [Related]
4. Schizophrenia and Parkinson's disease lead to equal motor-related changes in cortical and subcortical brain activation: an fMRI fingertapping study.
Müller JL; Deuticke C; Putzhammer A; Röder CH; Hajak G; Winkler J
Psychiatry Clin Neurosci; 2003 Dec; 57(6):562-8. PubMed ID: 14629703
[TBL] [Abstract][Full Text] [Related]
5. "Normalization" of brain activation in schizophrenia. An fMRI study.
Lund A; Kroken R; Thomsen T; Hugdahl K; Smievoll AI; Barndon R; Iversen J; Landrø NI; Sundet K; Rund BR; Ersland L; Lundervold A; Asbjørnsen A
Schizophr Res; 2002 Dec; 58(2-3):333-5. PubMed ID: 12409175
[No Abstract] [Full Text] [Related]
6. Effects of olanzapine on cerebellar functional connectivity in schizophrenia measured by fMRI during a simple motor task.
Stephan KE; Magnotta VA; White T; Arndt S; Flaum M; O'Leary DS; Andreasen NC
Psychol Med; 2001 Aug; 31(6):1065-78. PubMed ID: 11513374
[TBL] [Abstract][Full Text] [Related]
7. Olanzapine versus haloperidol in the treatment of schizophrenia and schizoaffective and schizophreniform disorders: results of an international collaborative trial.
Tollefson GD; Beasley CM; Tran PV; Street JS; Krueger JA; Tamura RN; Graffeo KA; Thieme ME
Am J Psychiatry; 1997 Apr; 154(4):457-65. PubMed ID: 9090331
[TBL] [Abstract][Full Text] [Related]
8. Superior efficacy of olanzapine over haloperidol: analysis of patients with schizophrenia from a multicenter international trial.
Gomez JC; Crawford AM
J Clin Psychiatry; 2001; 62 Suppl 2():6-11. PubMed ID: 11232753
[TBL] [Abstract][Full Text] [Related]
9. The relationship between negative symptoms of schizophrenia and extrapyramidal side effects with haloperidol and olanzapine.
Allan ER; Sison CE; Alpert M; Connolly B; Crichton J
Psychopharmacol Bull; 1998; 34(1):71-4. PubMed ID: 9564201
[TBL] [Abstract][Full Text] [Related]
10. Negative symptoms: a path analytic approach to a double-blind, placebo- and haloperidol-controlled clinical trial with olanzapine.
Tollefson GD; Sanger TM
Am J Psychiatry; 1997 Apr; 154(4):466-74. PubMed ID: 9090332
[TBL] [Abstract][Full Text] [Related]
11. The effects of olanzapine, risperidone, and haloperidol on plasma prolactin levels in patients with schizophrenia.
David SR; Taylor CC; Kinon BJ; Breier A
Clin Ther; 2000 Sep; 22(9):1085-96. PubMed ID: 11048906
[TBL] [Abstract][Full Text] [Related]
12. Changes in perceived health and functioning as a cost-effectiveness measure for olanzapine versus haloperidol treatment of schizophrenia.
Tunis SL; Johnstone BM; Gibson PJ; Loosbrock DL; Dulisse BK
J Clin Psychiatry; 1999; 60 Suppl 19():38-45; discussion 46. PubMed ID: 10507279
[TBL] [Abstract][Full Text] [Related]
13. Reversal of rabbit syndrome with olanzapine.
Damodaran SS; Thankamma JK
Aust N Z J Psychiatry; 2000 Feb; 34(1):172-3. PubMed ID: 11185940
[No Abstract] [Full Text] [Related]
14. Olanzapine versus haloperidol treatment in first-episode psychosis.
Sanger TM; Lieberman JA; Tohen M; Grundy S; Beasley C; Tollefson GD
Am J Psychiatry; 1999 Jan; 156(1):79-87. PubMed ID: 9892301
[TBL] [Abstract][Full Text] [Related]
15. Long-term olanzapine treatment: weight change and weight-related health factors in schizophrenia.
Kinon BJ; Basson BR; Gilmore JA; Tollefson GD
J Clin Psychiatry; 2001 Feb; 62(2):92-100. PubMed ID: 11247108
[TBL] [Abstract][Full Text] [Related]
16. [Economic comparison of olanzapine versus haloperidol in treatment of schizophrenia in France].
Le Pen C; Lilliu H; Allicar MP; Olivier V; Gregor KJ
Encephale; 1999; 25(4):281-6. PubMed ID: 10546082
[TBL] [Abstract][Full Text] [Related]
17. Effective resolution with olanzapine of acute presentation of behavioral agitation and positive psychotic symptoms in schizophrenia.
Kinon BJ; Roychowdhury SM; Milton DR; Hill AL
J Clin Psychiatry; 2001; 62 Suppl 2():17-21. PubMed ID: 11232746
[TBL] [Abstract][Full Text] [Related]
18. Blind, controlled, long-term study of the comparative incidence of treatment-emergent tardive dyskinesia with olanzapine or haloperidol.
Tollefson GD; Beasley CM; Tamura RN; Tran PV; Potvin JH
Am J Psychiatry; 1997 Sep; 154(9):1248-54. PubMed ID: 9286184
[TBL] [Abstract][Full Text] [Related]
19. Olanzapine versus placebo and haloperidol: quality of life and efficacy results of the North American double-blind trial.
Hamilton SH; Revicki DA; Genduso LA; Beasley CM
Neuropsychopharmacology; 1998 Jan; 18(1):41-9. PubMed ID: 9408917
[TBL] [Abstract][Full Text] [Related]
20. Olanzapine compared with chlorpromazine in treatment-resistant schizophrenia.
Conley RR; Tamminga CA; Bartko JJ; Richardson C; Peszke M; Lingle J; Hegerty J; Love R; Gounaris C; Zaremba S
Am J Psychiatry; 1998 Jul; 155(7):914-20. PubMed ID: 9659857
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
